<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31882736</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>27</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>TDP-43 aggregation inside micronuclei reveals a potential mechanism for protein inclusion formation in ALS.</ArticleTitle><Pagination><StartPage>19928</StartPage><MedlinePgn>19928</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">19928</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-56483-y</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating progressive neurodegenerative disease with no known etiology. The formation of pathological protein inclusions, including RNA-binding proteins such as TDP-43 and rho guanine nucleotide exchange factor (RGNEF) are a hallmark of ALS. Despite intensive research, the mechanisms behind protein aggregate formation in ALS remains unclear. We have investigated the role of metabolic stress in protein aggregate formation analyzing how it is relevant to the co-aggregation observed between RGNEF and TDP-43 in motor neurons of ALS patients. Metabolic stress was able to induce formation of micronuclei, small nuclear fragments, in cultured cells. Notably, we observed the formation TDP-43 protein inclusions within micronuclei that co-aggregate with RGNEF and can be released to the cytoplasm. We observed that the leucine-rich domain of RGNEF is critical for its interaction with TDP-43 and localization in micronuclei. Finally, we described that micronuclei-like structures can be found in brain and spinal cord of ALS patients. This work is the first description of protein inclusion formation within micronuclei which also is linked with a neurodegenerative disease. The formation of TDP-43 inclusions within micronuclei induced by metabolic stress is a novel mechanism of protein aggregate formation which may have broad relevance for ALS and other neurodegenerative diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Droppelmann</LastName><ForeName>Cristian A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Molecular Medicine Group, Robarts Research Institute, Schulich School of Medicine &amp; Dentistry, Western University, London, Ontario, Canada. cdroppel@uwo.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos-Melo</LastName><ForeName>Danae</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Molecular Medicine Group, Robarts Research Institute, Schulich School of Medicine &amp; Dentistry, Western University, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moszczynski</LastName><ForeName>Alexander J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Molecular Medicine Group, Robarts Research Institute, Schulich School of Medicine &amp; Dentistry, Western University, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amzil</LastName><ForeName>Hind</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Molecular Medicine Group, Robarts Research Institute, Schulich School of Medicine &amp; Dentistry, Western University, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strong</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-1988-6262</Identifier><AffiliationInfo><Affiliation>Molecular Medicine Group, Robarts Research Institute, Schulich School of Medicine &amp; Dentistry, Western University, London, Ontario, Canada. mstrong@uwo.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neurological Sciences, Schulich School of Medicine &amp; Dentistry, Western University, London, Ontario, Canada. mstrong@uwo.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000627100">Tardbp protein, rat</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047468" MajorTopicYN="N">Immunoprecipitation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31882736</ArticleId><ArticleId IdType="pmc">PMC6934605</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-56483-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-019-56483-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Strong MJ, Kesavapany S, Pant HC. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy? J Neuropathol Exp Neurol. 2005;64:649&#x2013;664. doi: 10.1097/01.jnen.0000173889.71434.ea.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000173889.71434.ea</ArticleId><ArticleId IdType="pubmed">16106213</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ. The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS) J Neurol Sci. 2010;288:1&#x2013;12. doi: 10.1016/j.jns.2009.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2009.09.029</ArticleId><ArticleId IdType="pubmed">19840884</ArticleId></ArticleIdList></Reference><Reference><Citation>Droppelmann CA, Campos-Melo D, Ishtiaq M, Volkening K, Strong MJ. RNA metabolism in ALS: when normal processes become pathological. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:321&#x2013;336. doi: 10.3109/21678421.2014.881377.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.881377</ArticleId><ArticleId IdType="pubmed">24555412</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Jr., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J, et al. A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci USA. 2011;108:20881&#x2013;20890. doi: 10.1073/pnas.1109434108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1109434108</ArticleId><ArticleId IdType="pmc">PMC3248518</ArticleId><ArticleId IdType="pubmed">22065782</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J, et al. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21:2899&#x2013;2911. doi: 10.1093/hmg/dds116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds116</ArticleId><ArticleId IdType="pmc">PMC3373238</ArticleId><ArticleId IdType="pubmed">22454397</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins M, et al. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients. Acta Neuropathol. 2012;124:717&#x2013;732. doi: 10.1007/s00401-012-1045-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1045-x</ArticleId><ArticleId IdType="pmc">PMC3472056</ArticleId><ArticleId IdType="pubmed">22993125</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller BA, et al. Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism. Acta Neuropathol. 2012;124:733&#x2013;747. doi: 10.1007/s00401-012-1035-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1035-z</ArticleId><ArticleId IdType="pubmed">22941224</ArticleId></ArticleIdList></Reference><Reference><Citation>Droppelmann CA, Keller BA, Campos-Melo D, Volkening K, Strong MJ. Rho guanine nucleotide exchange factor is an NFL mRNA destabilizing factor that forms cytoplasmic inclusions in amyotrophic lateral sclerosis. Neurobiol Aging. 2013;34:248&#x2013;262. doi: 10.1016/j.neurobiolaging.2012.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.06.021</ArticleId><ArticleId IdType="pubmed">22835604</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495:467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YR, King OD, Shorter J, Gitler AD. Stress granules as crucibles of ALS pathogenesis. J Cell Biol. 2013;201:361&#x2013;372. doi: 10.1083/jcb.201302044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201302044</ArticleId><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswami M, Taylor JP, Parker R. Altered ribostasis: RNA-protein granules in degenerative disorders. Cell. 2013;154:727&#x2013;736. doi: 10.1016/j.cell.2013.07.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.07.038</ArticleId><ArticleId IdType="pmc">PMC3811119</ArticleId><ArticleId IdType="pubmed">23953108</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A, Vande Velde C. Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS? Front Cell Neurosci. 2015;9:423. doi: 10.3389/fncel.2015.00423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00423</ArticleId><ArticleId IdType="pmc">PMC4615823</ArticleId><ArticleId IdType="pubmed">26557057</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey CM, et al. TDP-43 aggregation in neurodegeneration: are stress granules the key? Brain Res. 2012;1462:16&#x2013;25. doi: 10.1016/j.brainres.2012.02.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.02.032</ArticleId><ArticleId IdType="pmc">PMC3372581</ArticleId><ArticleId IdType="pubmed">22405725</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B. Regulated protein aggregation: stress granules and neurodegeneration. Mol Neurodegener. 2012;7:56. doi: 10.1186/1750-1326-7-56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-56</ArticleId><ArticleId IdType="pmc">PMC3519755</ArticleId><ArticleId IdType="pubmed">23164372</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S, Mateju D, Mediani L, Carra S. Granulostasis: Protein Quality Control of RNP Granules. Front Mol Neurosci. 2017;10:84. doi: 10.3389/fnmol.2017.00084.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00084</ArticleId><ArticleId IdType="pmc">PMC5367262</ArticleId><ArticleId IdType="pubmed">28396624</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L, et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One. 2010;5:e13250. doi: 10.1371/journal.pone.0013250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013250</ArticleId><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, et al. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem. 2009;284:20329&#x2013;20339. doi: 10.1074/jbc.M109.010264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, et al. An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat Struct Mol Biol. 2011;18:822&#x2013;830. doi: 10.1038/nsmb.2053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2053</ArticleId><ArticleId IdType="pmc">PMC3357956</ArticleId><ArticleId IdType="pubmed">21666678</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey CM, et al. TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol Cell Biol. 2011;31:1098&#x2013;1108. doi: 10.1128/MCB.01279-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01279-10</ArticleId><ArticleId IdType="pmc">PMC3067820</ArticleId><ArticleId IdType="pubmed">21173160</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C, et al. TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem. 2009;111:1051&#x2013;1061. doi: 10.1111/j.1471-4159.2009.06383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H, et al. Metabolic dysfunction in Alzheimer&#x2019;s disease and related neurodegenerative disorders. Curr Alzheimer Res. 2012;9:5&#x2013;17. doi: 10.2174/156720512799015064.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720512799015064</ArticleId><ArticleId IdType="pmc">PMC4097094</ArticleId><ArticleId IdType="pubmed">22329649</ArticleId></ArticleIdList></Reference><Reference><Citation>Funalot B, Desport JC, Sturtz F, Camu W, Couratier P. High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:113&#x2013;117. doi: 10.1080/17482960802295192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802295192</ArticleId><ArticleId IdType="pubmed">18792852</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano G, et al. Impaired oxidative metabolism in exercising muscle from ALS patients. J Neurol Sci. 2001;191:61&#x2013;65. doi: 10.1016/S0022-510X(01)00620-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00620-7</ArticleId><ArticleId IdType="pubmed">11676993</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano G, et al. Impaired oxidative metabolism and lipid peroxidation in exercising muscle from ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3:57&#x2013;62. doi: 10.1080/146608202760196011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608202760196011</ArticleId><ArticleId IdType="pubmed">12215226</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001;74:328&#x2013;334. doi: 10.1093/ajcn/74.3.328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/74.3.328</ArticleId><ArticleId IdType="pubmed">11522556</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat PF, et al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:166&#x2013;171. doi: 10.3109/17482960902822960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902822960</ArticleId><ArticleId IdType="pubmed">20184518</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellen KE, Thompson CB. Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell. 2010;40:323&#x2013;332. doi: 10.1016/j.molcel.2010.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.10.004</ArticleId><ArticleId IdType="pmc">PMC3190402</ArticleId><ArticleId IdType="pubmed">20965425</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung K, et al. Rho guanine nucleotide exchange factor (RGNEF) is a prosurvival factor under stress conditions. Mol Cell Neurosci. 2017;82:88&#x2013;95. doi: 10.1016/j.mcn.2017.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2017.05.003</ArticleId><ArticleId IdType="pubmed">28495450</ArticleId></ArticleIdList></Reference><Reference><Citation>Hintzsche H, et al. Fate of micronuclei and micronucleated cells. Mutat Res. 2017;771:85&#x2013;98. doi: 10.1016/j.mrrev.2017.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrrev.2017.02.002</ArticleId><ArticleId IdType="pubmed">28342454</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly P, Cleveland DW. Rebuilding Chromosomes After Catastrophe: Emerging Mechanisms of Chromothripsis. Trends Cell Biol. 2017;27:917&#x2013;930. doi: 10.1016/j.tcb.2017.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2017.08.005</ArticleId><ArticleId IdType="pmc">PMC5696049</ArticleId><ArticleId IdType="pubmed">28899600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bella J, Hindle KL, McEwan PA, Lovell SC. The leucine-rich repeat structure. Cell Mol Life Sci. 2008;65:2307&#x2013;2333. doi: 10.1007/s00018-008-8019-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-008-8019-0</ArticleId><ArticleId IdType="pubmed">18408889</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavolieri MV, Droppelmann CA, Campos-Melo D, Volkening K, Strong MJ. A novel overlapping NLS/NES region within the PH domain of Rho Guanine Nucleotide Exchange Factor (RGNEF) regulates its nuclear-cytoplasmic localization. Eur J Cell Biol. 2019;98:27&#x2013;35. doi: 10.1016/j.ejcb.2018.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcb.2018.11.001</ArticleId><ArticleId IdType="pubmed">30482479</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117:137&#x2013;149. doi: 10.1007/s00401-008-0477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0477-9</ArticleId><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Inukai Y, et al. Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS. FEBS Lett. 2008;582:2899&#x2013;2904. doi: 10.1016/j.febslet.2008.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2008.07.027</ArticleId><ArticleId IdType="pubmed">18656473</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatch EM, Fischer AH, Deerinck TJ, Hetzer MW. Catastrophic nuclear envelope collapse in cancer cell micronuclei. Cell. 2013;154:47&#x2013;60. doi: 10.1016/j.cell.2013.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.06.007</ArticleId><ArticleId IdType="pmc">PMC3749778</ArticleId><ArticleId IdType="pubmed">23827674</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw G, Morse S, Ararat M, Graham FL. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 2002;16:869&#x2013;871. doi: 10.1096/fj.01-0995fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.01-0995fje</ArticleId><ArticleId IdType="pubmed">11967234</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens PJ, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 2011;144:27&#x2013;40. doi: 10.1016/j.cell.2010.11.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.11.055</ArticleId><ArticleId IdType="pmc">PMC3065307</ArticleId><ArticleId IdType="pubmed">21215367</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D, Droppelmann CA, Volkening K, Strong MJ. RNA-binding proteins as molecular links between cancer and neurodegeneration. Biogerontology. 2014;15:587&#x2013;610. doi: 10.1007/s10522-014-9531-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-014-9531-2</ArticleId><ArticleId IdType="pubmed">25231915</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliore L, Coppede F, Fenech M, Thomas P. Association of micronucleus frequency with neurodegenerative diseases. Mutagenesis. 2011;26:85&#x2013;92. doi: 10.1093/mutage/geq067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mutage/geq067</ArticleId><ArticleId IdType="pubmed">21164187</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, et al. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163:123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y, et al. PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins. Cell Res. 2019;29:233&#x2013;247. doi: 10.1038/s41422-019-0141-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-019-0141-z</ArticleId><ArticleId IdType="pmc">PMC6460439</ArticleId><ArticleId IdType="pubmed">30728452</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, et al. Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization. Mol Cell. 2018;71:703&#x2013;717 e709. doi: 10.1016/j.molcel.2018.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.07.002</ArticleId><ArticleId IdType="pmc">PMC6128762</ArticleId><ArticleId IdType="pubmed">30100264</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopal PP, Nirschl JJ, Klinman E, Holzbaur EL. Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons. Proc Natl Acad Sci USA. 2017;114:E2466&#x2013;E2475. doi: 10.1073/pnas.1614462114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1614462114</ArticleId><ArticleId IdType="pmc">PMC5373408</ArticleId><ArticleId IdType="pubmed">28265061</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S, et al. RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science. 2018;360:918&#x2013;921. doi: 10.1126/science.aar7366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aar7366</ArticleId><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacco E, et al. RNA as a key factor in driving or preventing self-assembly of the TAR DNA-binding protein 43. J Mol Biol. 2019;431:1671&#x2013;1688. doi: 10.1016/j.jmb.2019.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2019.01.028</ArticleId><ArticleId IdType="pmc">PMC6461199</ArticleId><ArticleId IdType="pubmed">30742796</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Jimenez EP, et al. Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer&#x2019;s disease. Nat Med. 2019;25:554&#x2013;560. doi: 10.1038/s41591-019-0375-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0375-9</ArticleId><ArticleId IdType="pubmed">30911133</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusanescu G. Adult spinal cord neurogenesis: A regulator of nociception. Neurogenesis (Austin) 2016;3:e1256853. doi: 10.1080/23262133.2016.1256853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23262133.2016.1256853</ArticleId><ArticleId IdType="pmc">PMC5384611</ArticleId><ArticleId IdType="pubmed">28405586</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, et al. A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J Neurosci. 2004;24:4070&#x2013;4081. doi: 10.1523/JNEUROSCI.0346-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0346-04.2004</ArticleId><ArticleId IdType="pmc">PMC6729428</ArticleId><ArticleId IdType="pubmed">15102922</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy A, Kucukural A, Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc. 2010;5:725&#x2013;738. doi: 10.1038/nprot.2010.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2010.5</ArticleId><ArticleId IdType="pmc">PMC2849174</ArticleId><ArticleId IdType="pubmed">20360767</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, et al. The I-TASSER Suite: protein structure and function prediction. Nat Methods. 2015;12:7&#x2013;8. doi: 10.1038/nmeth.3213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3213</ArticleId><ArticleId IdType="pmc">PMC4428668</ArticleId><ArticleId IdType="pubmed">25549265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>